期刊文献+

慢病毒介导小干扰RNA沉默人结肠癌HT-29细胞芳香烃受体核转位蛋白基因的研究 被引量:5

Lentivirus-mediated small interfering RNA silencing aryl hydrocarbon receptor nuclear translocatorgene in human colon cancer cells HT29
原文传递
导出
摘要 目的获取有效沉默人结肠癌HT29细胞的芳香烃受体核转位蛋白基因(ARNT)的短发卡RNA(shRNA)重组慢病毒。方法构建4组表达ARNT—shRNA的慢病毒载体和1组无效干扰慢病毒载体并测序鉴定。用合成的5组重组慢病毒转染HT29细胞,通过克隆稀释扩大培养获取5组稳定转染细胞株,实时荧光定量聚合酶链反应(FQ—PCR)和Westernblot检测沉默效率。结果成功构建4组表达ARNT.shRNA的重组慢病毒,其中1组(LV—ARNT—RNAi一3)转染HT29细胞后能有效沉默ARNT基因,mRNA相对表达下降70%(P〈0.05),蛋白水平表达下降60%(P〈0.05)。结论重组慢病毒LV—ARNT—RNAi一3可以下调人结肠癌HT29细胞ARNT基因的表达。 Objective To obtain the recombinant lentivirus vector with expressing aryl hydrocar- bon receptor nuclear translocator (ARNT)-short hairpin RNA (shRNA) that could suppress the expression of ARNT gene in human colorectal cancer HT29 cells effectively. Methods Construct four lentiviral vector with expressing ARNT-shRNA and a negative control lentiviral vector and have the sequencing appraisal. After the five recombinant lentivirus vector were transfected into the HT29 cells, gain five stable transfection cell lines through enlarging cultivation of cloning dilution, the ARNT mRNA and protein expression were ex- amined by real-time quantitative polymerase chain reaction and Western blotting, respectively. Results Four groups of recombinant lentivirus vector that could express ARNT-shRNA were successfully construc- ted. One of the groups ( LV-ARNT-RNAi-3 ) could significantly suppress the expression of ARNT gene in HT29 cells, the mRNA expression fell by 70% ( P 〈 0. 05 ) and the protein expression fell by 60% ( P 〈 0. 05 ) ,respectively, compared with the control group. Conclusion LV-ARNT-RNAi-3 can efficiently in- hibit ARNT expression in HT29 cells.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第3期448-451,共4页 Chinese Journal of Experimental Surgery
基金 广东省科技计划资助项目(20108031600119)
关键词 慢病毒 芳香烃受体核转位蛋白 RNA干扰 HT29细胞株 Lentivirus Aryl hydrocarbon receptor nuclear translocator RNA interference HT29 cell line
  • 相关文献

参考文献2

二级参考文献10

  • 1张万广,朱虹,陈孝平,李东华,张必翔,张志伟.缺氧诱导因子-1α对HepG2细胞生长的影响及其初步机制[J].中华实验外科杂志,2006,23(10):1203-1205. 被引量:2
  • 2刘祺,龚凡杰,谭泽明,李永国,周建平.缺氧诱导对人结肠癌SW480细胞缺氧诱导因子-1α和Survivin基因表达的影响[J].中华实验外科杂志,2006,23(10):1228-1230. 被引量:10
  • 3Toffoli S,Michiels C.Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours.FEBS J,2008,12:2991-3002.
  • 4Semenza GL.Targeting HIF-1 for cancer therapy.Nat Rev Cancer,2003,10:721-732.
  • 5Martinive P,Defresne F,Bouzin C,et al.Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia:implications for anticancer therapies.Cancer Res,2006,66:11736-11744.
  • 6Sung JJ,Choi SY,Chart FK,et al.Obstacles to colorectal cancer screening in Chinese:a study based on the health belief model.Am J Gas Troenterol,2008,103:974-981.
  • 7Dewhirst MW,Cao Y,Moeller B,et al.Cycling hyporxia and free radicals regulate angiogenesis and radiotherapy response.Nat Rev Cancer,2008,8:425-437.
  • 8Baudelet C,Cron GO,AnsiauLx R,et al.The role of vessel maturation and vessel functionality in spontaneous fluctuations of T2 *-weighted GRE signal within tumors.NMR Biomed,2006,19:69-76.
  • 9Brahimi-Hom C,Pouyssegur J.The role of the hyposia-inaucible factorin tumor metabolism growth and invasion.Bull Cancer,2006,93:73-80.
  • 10刘丰,傅仲学,宋炯.Survivin的表达与直肠癌细胞凋亡、血管形成及预后的关系[J].中国现代普通外科进展,2004,7(3):162-164. 被引量:14

共引文献4

同被引文献36

  • 1Higuchi R,Fockler C,Dollinger G,et al.Kinetic PCR analysis:realtime monitoring of DNA amplification reactions.Biotechnology (NY),1993,11:1026-1030.
  • 2Shirasaki F,Takata M,Hatta N,et al.Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23.Cancer Res,2001,61:7422-7425.
  • 3Lee JH,Miele ME,Hicks DJ,et al.Kissl,a novel human malignant melanoma metastasis-suppressor gene.Natl Cancer Inst,1996,88:1731-1737.
  • 4Khelifa A,Laura T,Smith AG.et al.Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma.Carcinogenesis,2011,32:1467-1473.
  • 5Li C,Rossomando A,Wu SL,et al. Comparability analysis of anti-CD20 commercial(rituximab) and RNAi-mediated fucosylated antibodies by two LC-MS approaches [J]. MAbs,2013,5(4) :565-575.
  • 6Vengut-Climent E,Terrazas M, Lucas R, et al. Synthesis, RNAi activity and nuclease-resistant properties of apolarcarbohydrates siRNA conjugates[J]. Bioorg Med Chem Lett,2013,23(14) :4048-4051.
  • 7Ambrosini G, Adida C, Ahieri DC. A novel anti-apoptosis gene, Survivin, expressed in cancer and lymphoma[J]. Nat Med,1997,3(8) :917-921.
  • 8Kunze D, Erdmann K, Froehner M, et al. Enhanced inhibi- tion of bladder cancer cell growth by simultaneous knock- down of antiapoptotic Bcl-xL and survivin in combination with chemotherapy[J]. Int J Mol Sci,2013,14(6) : 12297- 12312.
  • 9Sarti M,Pinton S, Limoni C, et al. Differential expression of testin and survivin in breast cancer subtypes[J]. Oncol Rep, 2013,30(2) : 824-832.
  • 10Portanova P, Notaro A, Pellerito O, et a[. Notch inhibition restores TRAIL-mediated apoptosis via APl-dependent upregulation of DR4 and DR5 TRAIL receptors in MDA- MB-231 breast cancer eells[J]. Int J Oncol,2013,43(1) : 121-130.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部